CAMP CAMP4 Therapeutics Corporation

NASDAQ
$4.00

CAMP4 Therapeutics Corporation (CAMP) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bearish Selling ran elevated versus CAMP's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 1 buyer in the last 90 days 1 seller in the last 90 days
Insiders buying
1
1 transaction
Insiders selling
1
2 transactions
Purchases
$39.6K
10,000 shares
Sales
$1.6M
400,010 shares
Net activity
-$1.6M
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $1.6M 2 transactions · 400,010 shares

Largest single sale: $1.6M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: August 31, 2026 , by Gold Kelly .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Gold Kelly Chief Financial Officer Buy 10,000 $3.96 $39.6K 10,000
Schwab Andrew J. Director Sell 400,000 $4.04 $1.6M 2,033,270 −16.4% of holding
Schwab Andrew J. Director Sell 10 $4.50 $45 2,433,270 −0% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.